香港股市 已收市

Penumbra, Inc. (PEN)

NYSE - NYSE 延遲價格。貨幣為 USD。
加入追蹤清單
226.38+5.51 (+2.49%)
收市:04:00PM EDT
223.02 -3.49 (-1.54%)
收市後: 04:06PM EDT

Penumbra, Inc.

One Penumbra Place
Alameda, CA 94502
United States
510 748 3200
https://www.penumbrainc.com

版塊Healthcare
行業Medical Devices
全職員工4,200

高階主管

名稱頭銜支付行使價出生年份
Mr. Adam ElsesserCo-Founder, Chairman, President & CEO601.62k3.66M1962
Dr. Arani Bose M.D.Co-Founder & Director37.5k1962
Ms. Maggie S. YuenChief Financial Officer660.98k1973
Mr. Lambert ShiuChief Accounting Officer539.15k269.12k1981
Ms. Johanna RobertsExecutive VP, General Counsel & Secretary655.75k4.61M1972
Mr. Ben SorciExecutive Vice President of Operations
Mr. Pankaj TiwariExecutive VP & Chief Information Officer
Ms. Jee Hamlyn-HarrisInvestor Relations Officer
Mr. Ben TompkinsExecutive Vice President of Development
Ms. Gita BarryPresident of Immersive Healthcare
截止 2022年12月31日為止計算的金額,現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。

描述

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.

公司管治

截至 2024年3月1日 止,Penumbra, Inc. 的 ISS 管治質素評分為 7。 Pillar 分數正在審核中:9;董事會:6;股東權利:7;現金賠償:7。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。